TVTX logo

Travere Therapeutics (TVTX) Cost Of Goods Sold

Annual Cost Of Goods Sold

$11.45 M
+$7.03 M+159.05%

December 31, 2023


Summary


Performance

TVTX Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXexpensesmetrics:

Quarterly Cost Of Goods Sold

$1.63 M
-$435.00 K-21.11%

September 30, 2024


Summary


Performance

TVTX Quarterly Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXexpensesmetrics:

TTM Cost Of Goods Sold

$9.76 M
+$337.00 K+3.58%

September 30, 2024


Summary


Performance

TVTX TTM Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXexpensesmetrics:

Cost Of Goods Sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

TVTX Cost Of Goods Sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+159.1%-64.4%-14.8%
3 y3 years+86.9%+87.3%+58.1%
5 y5 years+107.2%+87.3%+58.1%

TVTX Cost Of Goods Sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+199.9%-64.4%+252.0%-14.8%+155.5%
5 y5-yearat high+199.9%-64.4%+252.0%-14.8%+155.5%
alltimeall timeat high+1905.3%-64.4%+252.0%-14.8%>+9999.0%

Travere Therapeutics Cost Of Goods Sold History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.63 M(-21.1%)
$9.76 M(+3.6%)
Jun 2024
-
$2.06 M(+37.0%)
$9.42 M(+6.9%)
Mar 2024
-
$1.50 M(-67.0%)
$8.81 M(-23.1%)
Dec 2023
$11.45 M(+159.0%)
$4.56 M(+254.1%)
$11.45 M(+47.7%)
Sep 2023
-
$1.29 M(-11.2%)
$7.75 M(+2.3%)
Jun 2023
-
$1.45 M(-65.0%)
$7.58 M(-7.3%)
Mar 2023
-
$4.14 M(+377.5%)
$8.18 M(+32.5%)
Dec 2022
$4.42 M(+15.8%)
$868.00 K(-22.1%)
$6.17 M(+45.8%)
Sep 2022
-
$1.11 M(-45.7%)
$4.23 M(-10.1%)
Jun 2022
-
$2.05 M(-4.1%)
$4.71 M(+9.3%)
Mar 2022
-
$2.14 M(-299.8%)
$4.31 M(+12.9%)
Dec 2021
$3.82 M(-37.7%)
-$1.07 M(-167.2%)
$3.82 M(-45.1%)
Sep 2021
-
$1.59 M(-3.6%)
$6.96 M(+6.1%)
Jun 2021
-
$1.65 M(+0.4%)
$6.56 M(+2.5%)
Mar 2021
-
$1.65 M(-20.6%)
$6.40 M(+4.5%)
Dec 2020
$6.13 M(+17.0%)
$2.07 M(+74.3%)
$6.13 M(+6.0%)
Sep 2020
-
$1.19 M(-20.4%)
$5.78 M(-5.3%)
Jun 2020
-
$1.49 M(+9.1%)
$6.10 M(+9.2%)
Mar 2020
-
$1.37 M(-20.6%)
$5.59 M(+6.7%)
Dec 2019
$5.23 M
$1.73 M(+14.0%)
$5.23 M(+2.4%)
Sep 2019
-
$1.51 M(+54.5%)
$5.11 M(+8.0%)
DateAnnualQuarterlyTTM
Jun 2019
-
$979.00 K(-3.7%)
$4.73 M(-4.0%)
Mar 2019
-
$1.02 M(-36.6%)
$4.93 M(-10.8%)
Dec 2018
$5.53 M(+53.3%)
$1.60 M(+41.5%)
$5.53 M(+8.4%)
Sep 2018
-
$1.13 M(-3.8%)
$5.10 M(+4.3%)
Jun 2018
-
$1.18 M(-27.0%)
$4.89 M(+8.4%)
Mar 2018
-
$1.61 M(+37.4%)
$4.51 M(+25.1%)
Dec 2017
$3.60 M(-20.8%)
$1.17 M(+26.9%)
$3.60 M(-0.8%)
Sep 2017
-
$925.00 K(+16.1%)
$3.63 M(-15.1%)
Jun 2017
-
$797.00 K(+12.4%)
$4.28 M(-5.0%)
Mar 2017
-
$709.00 K(-41.1%)
$4.51 M(-1.1%)
Dec 2016
$4.55 M(+108.4%)
$1.20 M(-23.5%)
$4.55 M(+10.7%)
Sep 2016
-
$1.57 M(+54.1%)
$4.11 M(+34.7%)
Jun 2016
-
$1.02 M(+34.9%)
$3.05 M(+14.4%)
Mar 2016
-
$757.00 K(-0.5%)
$2.67 M(+22.1%)
Dec 2015
$2.19 M(+282.7%)
$761.00 K(+48.3%)
$2.19 M(+24.0%)
Sep 2015
-
$513.00 K(-19.5%)
$1.76 M(+21.8%)
Jun 2015
-
$637.00 K(+132.5%)
$1.45 M(+71.2%)
Mar 2015
-
$274.00 K(-18.9%)
$845.00 K(+47.8%)
Dec 2014
$571.00 K
$338.00 K(+70.7%)
$571.90 K(+144.5%)
Sep 2014
-
$198.00 K(+465.7%)
$233.90 K(+551.5%)
Jun 2014
-
$35.00 K(+3788.9%)
$35.90 K(+3888.9%)
Mar 2014
-
$900.00
$900.00

FAQ

  • What is Travere Therapeutics annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Travere Therapeutics?
  • What is Travere Therapeutics annual cost of goods sold year-on-year change?
  • What is Travere Therapeutics quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Travere Therapeutics?
  • What is Travere Therapeutics quarterly cost of goods sold year-on-year change?
  • What is Travere Therapeutics TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Travere Therapeutics?
  • What is Travere Therapeutics TTM cost of goods sold year-on-year change?

What is Travere Therapeutics annual cost of goods sold?

The current annual cost of goods sold of TVTX is $11.45 M

What is the all time high annual cost of goods sold for Travere Therapeutics?

Travere Therapeutics all-time high annual cost of goods sold is $11.45 M

What is Travere Therapeutics annual cost of goods sold year-on-year change?

Over the past year, TVTX annual cost of goods sold has changed by +$7.03 M (+159.05%)

What is Travere Therapeutics quarterly cost of goods sold?

The current quarterly cost of goods sold of TVTX is $1.63 M

What is the all time high quarterly cost of goods sold for Travere Therapeutics?

Travere Therapeutics all-time high quarterly cost of goods sold is $4.56 M

What is Travere Therapeutics quarterly cost of goods sold year-on-year change?

Over the past year, TVTX quarterly cost of goods sold has changed by -$2.94 M (-64.37%)

What is Travere Therapeutics TTM cost of goods sold?

The current TTM cost of goods sold of TVTX is $9.76 M

What is the all time high TTM cost of goods sold for Travere Therapeutics?

Travere Therapeutics all-time high TTM cost of goods sold is $11.45 M

What is Travere Therapeutics TTM cost of goods sold year-on-year change?

Over the past year, TVTX TTM cost of goods sold has changed by -$1.70 M (-14.80%)